Evidence map›Paper›PMID 17928425›Full record

ArticleJournal of clinical microbiology2007

Evaluation of a multiplexed PCR assay for detection of respiratory viral pathogens in a public health laboratory setting.

David J Marshall, Erik Reisdorf, Gerda Harms, Edward Beaty, Michael J Moser, Wai-Ming Lee, James E Gern, Frederick S Nolte, Pete Shult, James R Prudent

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2018
    Pooled it
  2. Article
  3. Laboratory diagnosis of viral infection.Handbook of clinical neurology · 2014
    Review
  4. Article
  5. Article
  6. Article
  7. The microarray technology: facts and controversies.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2013
    Review
  8. Article
  9. Article
  10. Use and evaluation of molecular diagnostics for pneumonia etiology studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Review
  11. Article
  12. Article
  13. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.American journal of respiratory and critical care medicine · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Molecular diagnosis of viral respiratory infections.Current infectious disease reports · 2011
    Article
  18. Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David J MarshallEraGen Biosciences Inc, Madison, WI 53717, USA. dmarshall@eragen.com
Erik Reisdorf
Gerda Harms
Edward Beaty
Michael J Moser
Wai-Ming Lee
James E Gern
Frederick S Nolte
Pete Shult
James R Prudent

Funding

RV-Mediated Mechanisms of Neutrophil Motility /InflammatU19AI070503 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2006 to 2010
$6.8M
NIAID NIH HHS U19 AI070503
6 · The paper itself

Abstract

There are numerous viral and bacterial causes of respiratory disease. To enable rapid and sensitive detection of even the most prevalent causes, there is a need for more-simplified testing systems that enable researchers and clinicians to perform multiplexed molecular diagnostics quickly and easily. To this end, a new multiplexed molecular test called the MultiCode-PLx respiratory virus panel (PLx-RVP) was developed and then implemented in a public health laboratory setting. A total of 687 respiratory samples were analyzed for the presence of 17 viruses that commonly cause respiratory disease. As a comparator, the samples were also tested using a standard testing algorithm that included the use of a real-time influenza virus A and B reverse transcription-PCR test and routine viral culture identification. The standard testing algorithm identified 503 (73%) samples as positive and 184 as negative. Analyzing the same 687 samples, the PLx-RVP assay detected one or more targets in 528 (77%) samples and found 159 samples negative for all targets. There were 25 discordant results between the two systems; 14 samples were positive for viruses not routinely tested for by the Wisconsin State Laboratory of Hygiene, and 13 of these were confirmed by real-time PCR. When the results of the standard testing algorithm were considered "true positives," the PLx-RVP assay showed an overall sensitivity of 99% and an overall specificity of 87%. In total, the PLx-RVP assay detected an additional 40 viral infections, of which 11 were mixed infections.

Indexed as

HumansPolymerase Chain ReactionRespiratory Tract InfectionsSensitivity and SpecificityVirus CultivationVirus DiseasesViruses

Identifiers

PMID17928425
PMCPMC2168541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.